Publications by authors named "Robert P Aftring"
Diabetes Obes Metab
November 2019
Article Synopsis
- The study aimed to assess the safety and effectiveness of bexagliflozin, a medication for type 2 diabetes, over a 96-week period compared to a placebo.
- It involved 288 adults from the USA, Colombia, and Mexico, showing a significant reduction in HbA1c levels and beneficial changes in body mass and blood pressure for those taking bexagliflozin.
- The results indicated that bexagliflozin was well tolerated, with fewer serious adverse events and urinary tract infections compared to the placebo group, demonstrating it provided meaningful improvements in diabetes management.
